2016
DOI: 10.1371/journal.pone.0156692
|View full text |Cite|
|
Sign up to set email alerts
|

Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli

Abstract: L-asparaginase is an enzyme used as a chemotherapeutic agent, mainly for treating acute lymphoblastic leukemia. In this study, the gene of L-asparaginase from Zymomonas mobilis was cloned in pET vectors, fused to a histidine tag, and had its codons optimized. The L-asparaginase was expressed extracellularly and intracellularly (cytoplasmically) in Escherichia coli in far larger quantities than obtained from the microorganism of origin, and sufficient for initial cytotoxicity tests on leukemic cells. The in sil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(15 citation statements)
references
References 48 publications
0
15
0
Order By: Relevance
“…The Zymomonas mobilis species is likely related to ethanol production; it showed a high performance in response to external stresses such as high ethanol concentration, high temperature, and harsh acidic fermentation conditions (Wang et al, 2016;Zhang et al, 2016). In addition, Zymomonas mobilis has anti-leukemic activity, antitumor effects, and prebiotic activity (Einsfeldt et al, 2016;Lorenzetti et al, 2015;Yoon et al, 2004). No Acetobacter was detected in this study, despite representatives of this genus have previously been isolated from other tibicos (Gulitz et al, 2011;Marsh et al, 2013).…”
Section: Resultsmentioning
confidence: 64%
“…The Zymomonas mobilis species is likely related to ethanol production; it showed a high performance in response to external stresses such as high ethanol concentration, high temperature, and harsh acidic fermentation conditions (Wang et al, 2016;Zhang et al, 2016). In addition, Zymomonas mobilis has anti-leukemic activity, antitumor effects, and prebiotic activity (Einsfeldt et al, 2016;Lorenzetti et al, 2015;Yoon et al, 2004). No Acetobacter was detected in this study, despite representatives of this genus have previously been isolated from other tibicos (Gulitz et al, 2011;Marsh et al, 2013).…”
Section: Resultsmentioning
confidence: 64%
“…The role of chemical modifications and protein engineering in improving the effectiveness of medicines is also discussed. Currently, as an alternative to bacterial L-ASNases with chemotherapeutic use, several type II bacterial enzymes are under consideration: Thermus thermophiles , Proteus vulgaris , Pseudomonas fluorescens , Serratia marcescens , Erwinia aroidea , Aspergillus terreus , Mycobacterium tuberculosis , Yersinia pseudotuberculosis , recombinant Saccharomyces cerevisiae , Halomonas elongata , Sarocladium strictum , Streptomyces rochei , Aspergillus terreus , Fusarium culmorum and Zymomonas mobilis [ 62 , 138 , 139 , 140 , 141 , 142 ]. They all have antiproliferative activities toward cancer cells.…”
Section: Alternative Approaches To the Development Of Antitumor L-asn...mentioning
confidence: 99%
“…In the present study we have described the short chain L-asparaginase I for its characteristics and anticancer effects. Genetic engineering tools and techniques have been widely used for the production of enzyme from various resources (Einsfeldt et al, 2016;Saeed et al, 2018).…”
Section: In Silico Analysismentioning
confidence: 99%